Radiation-free Bone Imaging UTE MRI in Healthy and Diseased Patients
NCT ID: NCT03633032
Last Updated: 2023-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2018-10-01
2023-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UTE MRI
Acquiring of ultrashort echo time (UTE) MRI sequences
Modern MRI sequences (ultrashort echo time (UTE)) for a better depiction of bone anatomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acquiring of ultrashort echo time (UTE) MRI sequences
Modern MRI sequences (ultrashort echo time (UTE)) for a better depiction of bone anatomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for participants referred for a clinical indicated MRI (primary objective) inclusion criterion is the presence of radiographs or a CT scan of the part of the skeletal system that is under investigation within the clinical indicated MRI
* for healthy volunteers (secondary objective) any volunteer that is not referred for a clinical indicated MRI scan
Exclusion Criteria
* general known contraindications for MRI (e.g., non-MR compatible pacemaker)
* homeless persons, or persons with active drug/alcohol dependence or abuse history
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roman Guggenberger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roman Guggenberger
PD Dr. med. Roman Guggenberger, Sponsor-Investigator, Senior Physician, Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roman Guggenberger, MD, PD
Role: PRINCIPAL_INVESTIGATOR
Universitätsspital Zürich
Christian Kellenberger, MD
Role: PRINCIPAL_INVESTIGATOR
Kinderspital Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USZ_Radiationfree bone imaging
Identifier Type: -
Identifier Source: org_study_id